Cerity Partners LLC Grows Position in Veeva Systems Inc. $VEEV

Cerity Partners LLC grew its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 29.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 132,624 shares of the technology company’s stock after purchasing an additional 30,093 shares during the quarter. Cerity Partners LLC owned about 0.08% of Veeva Systems worth $39,510,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of VEEV. Vanguard Group Inc. boosted its holdings in Veeva Systems by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 14,971,425 shares of the technology company’s stock worth $4,311,471,000 after buying an additional 210,859 shares during the period. Alliancebernstein L.P. raised its holdings in Veeva Systems by 3.7% during the 2nd quarter. Alliancebernstein L.P. now owns 5,705,648 shares of the technology company’s stock valued at $1,643,113,000 after acquiring an additional 205,997 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Veeva Systems by 2.6% during the second quarter. JPMorgan Chase & Co. now owns 3,316,274 shares of the technology company’s stock worth $955,030,000 after acquiring an additional 85,516 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Veeva Systems by 3.8% in the second quarter. Geode Capital Management LLC now owns 3,092,539 shares of the technology company’s stock worth $888,108,000 after acquiring an additional 114,003 shares during the period. Finally, AQR Capital Management LLC grew its position in shares of Veeva Systems by 111.7% in the second quarter. AQR Capital Management LLC now owns 1,838,046 shares of the technology company’s stock valued at $526,508,000 after purchasing an additional 969,905 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

Analyst Ratings Changes

VEEV has been the topic of a number of recent research reports. Canaccord Genuity Group reissued a “buy” rating on shares of Veeva Systems in a report on Tuesday, November 25th. Citigroup lowered their price target on shares of Veeva Systems from $349.00 to $319.00 and set a “buy” rating on the stock in a report on Monday, November 24th. Wall Street Zen lowered shares of Veeva Systems from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Needham & Company LLC reaffirmed a “buy” rating and set a $355.00 target price on shares of Veeva Systems in a report on Friday, November 21st. Finally, William Blair reissued an “outperform” rating on shares of Veeva Systems in a report on Friday, October 17th. Nineteen investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva and BioMarin announced a long‑term strategic partnership to accelerate development and commercialization workflows — strengthens a customer relationship with recurring revenue and cross‑sell potential. Veeva and BioMarin Form Long-Term Strategic Partnership
• Positive Sentiment: Veeva launched an Environmental Monitoring solution to modernize quality‑control in manufacturing — expands Veeva’s manufacturing QC portfolio and creates new upsell opportunities to regulated customers. Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing
• Positive Sentiment: Novo Nordisk’s International Operations committed to Veeva Vault CRM — a significant commercial win that validates Veeva’s CRM and agentic AI positioning and can drive multi‑year recurring revenue. Novo Nordisk International Operations Commits to Veeva Vault CRM
• Positive Sentiment: The board authorized up to $2 billion to repurchase Class A shares — a sizable buyback that should support EPS and reduce float, typically viewed positively by investors. Veeva authorized to purchase up to $2B of shares of Class A stock
• Positive Sentiment: Analyst sentiment improved — Truist upgraded VEEV from hold to buy, and Stifel Nicolaus also published a buy — upgrades can lift demand and broker coverage. Veeva Systems (VEEV) Gets a Buy from Stifel Nicolaus
• Neutral Sentiment: Veeva will present at the J.P. Morgan 2026 Healthcare Conference — useful for investor visibility but not an immediate fundamental change. Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
• Neutral Sentiment: Multiple press stories noted the stock is trading up — reflects market reaction to the combination of the above items rather than new company fundamentals. Veeva Systems (VEEV) stock trades up, here is why

Veeva Systems Stock Performance

Veeva Systems stock opened at $241.31 on Friday. Veeva Systems Inc. has a fifty-two week low of $201.54 and a fifty-two week high of $310.50. The stock has a market cap of $39.67 billion, a P/E ratio of 46.95, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The firm’s fifty day moving average price is $247.98 and its 200-day moving average price is $271.38.

Veeva Systems (NYSE:VEEV) last released its earnings results on Thursday, November 20th. The technology company reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The business had revenue of $0.81 million for the quarter, compared to analysts’ expectations of $792.37 million. During the same quarter in the prior year, the firm earned $1.75 earnings per share. The firm’s revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. On average, analysts predict that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Veeva Systems announced that its Board of Directors has authorized a share buyback program on Monday, January 5th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the technology company to purchase up to 5.5% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.